• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2018

View Archived Issues

Aduro earns milestone from Merck & Co. for initiation of phase I trial of anti-CD27 antibody

Read More

Caladrius Biosciences acquires license to late-stage CD34+ cell therapy program from Shire

Read More

Eisai and Purdue Pharma report results from clinical studies of lemborexant

Read More

Pivotal phase III study of bempedoic acid in ASCVD meets primary endpoint

Read More

Vocimagene amiretrorepvec/5-fluorocytosine granted E.U. orphan designation for glioma

Read More

Researchers evaluate safety and immunogenicity of a new anti-allergic vaccine

Read More

MD Anderson Cancer Center and Berkeley Lights launch new company

Read More

Phase IIb study of BTK inhibitor in MS meets primary endpoint

Read More

Oxford Vacmedix closes series A funding to develop its two lead cancer vaccine candidates

Read More

NTP-42 receives E.U., U.S. orphan designations for pulmonary arterial hypertension

Read More

Compugen licenses SUREtechnology platform from Selexis

Read More

Antimicrobial polymers show killing activity without leading to resistance

Read More

University of Bristol presents new alpha4beta2 nicotinic receptor partial agonists

Read More

Novel NF-kappaB inhibitors synthesized at University College Dublin

Read More

Arena Pharmaceuticals patents new 5-HT2C receptor agonists

Read More

Genoimmune Therapeutics creates novel human leukocyte antigen-binding polypeptides

Read More

New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University

Read More

Evotec and Sanofi in negotiations over new open innovation platform in infectious disease

Read More

Eisai and Merck & Co. agree on strategic collaboration for Lenvima

Read More

Harbin Medical University presents data on PET tracer for EGFR mutation determination

Read More

Immuron announces topline phase II results for IMM-124E in NASH

Read More

MuSK stimulation preserves neuromuscular synapses in amyotrophic lateral sclerosis

Read More

Medicure to commercialize Zydus Cadila's pitavastatin in U.S.

Read More

Daiichi Sankyo initiates phase II study of DS-8201 in HER2-expressing colorectal cancer

Read More

Aevi Genomic Medicine and Kyowa Hakko Kirin expand collaboration

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe